Unibest
← Back to patent-cliff list

Flurpiridaz F-18

Tier C — Watch / trade

Flurpiridaz F-18

Bristol Myers Squibb
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Radiopharmaceutical
Type

Targets:Mitochondrial complex I (NADH dehydrogenase)

Brand:FLYRCADO

Indications (approved):Coronary artery disease, Ischaemic heart disease, Diagnostic agent

Regional status

US
Approved
2024-09-27
EU
Phase III
2011-06-01
China
-
Japan
-

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield /
FLUR-0016908-41-4FLUR-00275-21-8FLUR-00358334-93-3FLUR-004863888-28-2FLUR-005863888-29-3FLUR-00688093-48-5FLUR-007863888-30-6FLUR-008863888-31-7FLUR-009863888-32-8API · Flurpiridaz F-18
CodeCAS No.Intermediate
FLUR-0016908-41-4methyl 4-(hydroxymethyl)benzoate
FLUR-00275-21-8oxirane
FLUR-00358334-93-3methyl 4-((2-hydroxyethoxy)methyl)benzoate
FLUR-004863888-28-2methyl 4-((2-((tert-butyldimethylsilyl)oxy)ethoxy)methyl)benzoate
FLUR-005863888-29-3(4-((2-((tert-butyldimethylsilyl)oxy)ethoxy)methyl)phenyl)methanol
FLUR-00688093-48-52-(tert-butyl)-4-chloro-5-hydroxypyridazin-3(2H)-one
FLUR-007863888-30-62-(tert-butyl)-5-((4-((2-((tert-butyldimethylsilyl)oxy)ethoxy)methyl)benzyl)oxy)-4-chloropyridazin-3(2H)-one
FLUR-008863888-31-72-(tert-butyl)-4-chloro-5-((4-((2-hydroxyethoxy)methyl)benzyl)oxy)pyridazin-3(2H)-one
FLUR-009863888-32-82-((4-(((1-(tert-butyl)-5-chloro-6-oxo-1,6-dihydropyridazin-4-yl)oxy)methyl)benzyl)oxy)ethyl 4-methylbenzenesulfonate
OptimisedRoute 2Steps 4 · Total yield /
FLUR-008863888-31-7FLUR-01082727-12-6FLUR-011—FLUR-012—FLUR-013—API · Flurpiridaz F-18
CodeCAS No.Intermediate
FLUR-008863888-31-72-(tert-butyl)-4-chloro-5-((4-((2-hydroxyethoxy)methyl)benzyl)oxy)pyridazin-3(2H)-one
FLUR-01082727-12-6perfluoro-1,2,7-oxadithiepane 2,2,7,7-tetraoxide
FLUR-011--
FLUR-012--
FLUR-013--

Frequently asked questions

What are the approved indications of Flurpiridaz F-18?

Approved indications include: Coronary artery disease, Ischaemic heart disease, Diagnostic agent.

When does the Flurpiridaz F-18 patent expire?

No public expiry year is available for Flurpiridaz F-18 yet; this page updates once verified.

How many synthesis routes are recorded for Flurpiridaz F-18?

2 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Flurpiridaz F-18 intermediates?

All intermediates in Flurpiridaz F-18 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Flurpiridaz F-18 intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29